| Literature DB >> 24472561 |
Joo-Yong Na, Kuck-Hyun Woo, Seong-Yong Yoon, Seong-Yong Cho, In-Ung Song, Joo-An Kim, Jin-Seok Kim1.
Abstract
OBJECTIVES: This study was conducted to describe the demographic characteristics, and clinical signs and symptoms of patients who visited a general hospital because of the release of chemically hazardous hydrogen fluoride that occurred on September 27, 2012 in Gumi City, Korea.Entities:
Year: 2013 PMID: 24472561 PMCID: PMC3923353 DOI: 10.1186/2052-4374-25-17
Source DB: PubMed Journal: Ann Occup Environ Med ISSN: 2052-4374
Figure 1Map of the Gumi industrial complex and the surrounding residential area. The hydrogen fluoride spill area is designated by the red circle.
Details of the 12 hospitalized patients
| 30 | M | IP† | 9/28 | 9/29 | Dyspnea | Gas inhalation | Worker | No abnormal findings |
| 51 | F | IP | 10/3 | 10/10 | Hemoptysis | Bronchitis | Adjacent resident | Bronchoscopy ; hyperemic, both bronchi edematous |
| 52 | M | IP | 10/3 | 10/8 | Blood-tinged sputum | Bronchitis | Governmental officials | Bronchoscopy ; both bronchi hyperemic |
| 44 | F | IP | 10/9 | 10/12 | Dyspnea | Gas inhalation | Worker | No abnormal findings |
| 52 | F | IP | 10/16 | 10/25 | Dyspnea | Toxic effect of HF* | Adjacent resident | Anxiety |
| 38 | M | IP | 10/24 | 10/26 | Hemoptysis | Bronchitis | Worker | Bronchoscopy ; both bronchi hyperemic |
| 44 | F | IG‡ | 10/6 | 10/10 | Nausea | Gastric ulcer | Adjacent resident | GIF
|
| 68 | F | IG | 10/9 | 10/12 | Nausea | Gas inhalation | Adjacent resident | GIF; chronic atropic gastritis |
| 25 | F | ENT§ | 10/6 | 10/11 | Sore throat | Acute pharyngotonsillitis | Worker | Pharyngeal injection |
| 57 | F | NR
| 10/4 | 10/8 | Numbness | Numbness | Other resident (Intake of contaminated crops) | No abnormal findings |
| 79 | F | NR | 10/9 | 10/12 | Headache | Chronic tension headache | Adjacent resident | No abnormal findings |
| 71 | F | PS
| 10/8 | 10/8 | Lip pain | Chemical burn on lower lip | Other Resident (intake of contaminated crops) | Swelling, erythema on lower lip |
*Hydrogen fluoride, †Internal medicine, pulmonology, ‡Internal medicine, gastroenterology, §ENT; Otorhinolaryngology, Neurology, Plastric surgery, Gastro-intestinal fiberscopy.
Figure 2Distribution of numbers of non-hospitalized patients by day.
General characteristics of non-hospitalized patients
| Age(years) | | |
| 0–9 | 109 | 5.8 |
| 10–19 | 80 | 4.2 |
| 20–29 | 338 | 17.9 |
| 30–39 | 575 | 30.4 |
| 40–49 | 400 | 21.2 |
| 50–59 | 253 | 13.4 |
| ≥60 | 135 | 7.1 |
| Gender | | |
| Male | 997 | 52.8 |
| Female | 893 | 47.2 |
| First visit to the outpatient department | | |
| Occupational and environmental medicine | 1528 | 80.8 |
| Pediatrics | 136 | 7.2 |
| Internal medicine, Pulmonology | 130 | 6.9 |
| Emergency medicine | 55 | 2.9 |
| Ophthalmologic medicine | 22 | 1.1 |
| Otorhinolaryngology | 11 | 0.6 |
| Others | 9 | 0.6 |
| Exposure characteristics | | |
| Adjacent residents | 205 | 11.2 |
| Other residents | 575 | 31.5 |
| Workers | 728 | 39.9 |
| Firefighters | 38 | 2.1 |
| Police and public officials | 66 | 3.6 |
| Others | 211 | 11.6 |
| Location at the time of the accident | | |
| Indoor | 922 | 80.4 |
| Outdoor | 219 | 19.1 |
| Others | 6 | 0.5 |
| Time of first hospital visit | | |
| Within 3 days | 176 | 9.3 |
| After 4 days | 1714 | 90.7 |
| Distance from the place of the accident spot | | |
| Under 100 m | 227 | 14.6 |
| 100 m-1 km | 721 | 46.5 |
| Over 1 km | 603 | 38.9 |
Chief complaints of early and late patients
| Sore throat | 37 | 23.3 | 394 | 24.2 | 431 | 24.1 | 0.797 |
| Headache | 25 | 15.7 | 316 | 19.4 | 341 | 19.1 | 0.260 |
| Cough | 8 | 5.0 | 228 | 14.0 | 236 | 13.2 | 0.001 |
| Eye irritation | 17 | 10.7 | 147 | 9.0 | 164 | 9.2 | 0.487 |
| No symptom | 6 | 3.8 | 105 | 6.4 | 111 | 6.2 | 0.183 |
| Shortness of breath | 43 | 27.0 | 57 | 3.5 | 100 | 5.6 | 0.000 |
| Chest pain | 3 | 1.9 | 63 | 3.9 | 66 | 3.7 | 0.206 |
| Dizziness | 2 | 1.3 | 54 | 3.3 | 56 | 3.1 | 0.155 |
| Nausea | 10 | 6.3 | 43 | 2.6 | 53 | 3.0 | 0.010 |
| Rhinorrhea | 0 | 0.0 | 53 | 3.3 | 53 | 3.0 | 0.021 |
| Skin burning | 2 | 1.3 | 36 | 2.2 | 38 | 2.1 | 0.427 |
| Itching | 0 | 0.0 | 32 | 2.0 | 32 | 1.8 | 0.075 |
| Sputum | 1 | 0.6 | 26 | 1.6 | 27 | 1.5 | 0.340 |
| Nasal pain | 1 | 0.6 | 14 | 0.9 | 15 | 0.8 | 0.761 |
| Skin rash | 0 | 0.0 | 7 | 0.4 | 7 | 0.4 | 0.408 |
| Vomiting | 0 | 0.0 | 2 | 0.1 | 2 | 0.1 | 0.658 |
| Others | 4 | 2.5 | 52 | 3.2 | 56 | 3.1 | 0.640 |
| Total | 159 | 100.0 | 1629 | 100.0 | 1788 | 100.0 | |
* Early patients: hospital visit within 3 days.
† Late patients: hospital visit 4 days or after.
‡ Chi-squared test.
Symptom complaints of early and late patients
| Cough | 27 | 15.3 | 791 | 46.1 | 818 | 43.3 | 0.000 |
| Sore throat | 64 | 36.4 | 741 | 43.2 | 805 | 42.6 | 0.079 |
| Headache | 47 | 26.7 | 745 | 43.5 | 792 | 41.9 | 0.000 |
| Eye irritation | 35 | 19.9 | 536 | 31.3 | 571 | 30.2 | 0.002 |
| Nausea | 25 | 14.2 | 327 | 19.1 | 352 | 18.6 | 0.114 |
| Shortness of breath | 54 | 30.7 | 252 | 14.7 | 306 | 16.2 | 0.000 |
| Dizziness | 9 | 5.1 | 260 | 15.2 | 269 | 14.2 | 0.000 |
| Chest pain | 5 | 2.8 | 102 | 6.0 | 107 | 5.7 | 0.089 |
| Skin burning | 5 | 2.8 | 77 | 4.5 | 82 | 4.3 | 0.306 |
| Skin rash | 1 | 0.6 | 65 | 3.8 | 66 | 3.5 | 0.027 |
| Vomiting | 2 | 1.1 | 45 | 2.6 | 47 | 2.5 | 0.227 |
| Total | 176 | 100.0 | 1714 | 100.0 | 1890 | 100.0 | |
* Early patients: hospital visit within 3 days.
† Late patients: hospital visit 4 days or after.
‡ Chi-squared test.
Patient characteristics with respect to distance from the accident site
| Sex | | | | | | | 0.000 |
| Male | 149 | 65.6 | 418 | 58.0 | 249 | 41.3 | |
| Female | 78 | 34.4 | 303 | 42.0 | 354 | 58.7 | |
| Age | | | | | | | 0.000 |
| Under 19 | 7 | 3.1 | 22 | 3.0 | 50 | 8.3 | |
| 20~39 | 96 | 42.3 | 351 | 43.7 | 370 | 61.3 | |
| 40~59 | 117 | 51.5 | 273 | 37.9 | 162 | 26.9 | |
| Over 60 | 7 | 3.1 | 75 | 10.4 | 21 | 3.5 | |
| Exposure characteristics | | | | | | 0.000 | |
| Adjacent residents | 12 | 5.4 | 126 | 17.6 | 20 | 3.3 | |
| Other residents | 12 | 5.4 | 103 | 14.4 | 323 | 53.7 | |
| Workers | 103 | 46.6 | 408 | 56.9 | 187 | 31.1 | |
| Firefighters | 19 | 8.6 | 1 | 0.1 | 3 | 0.5 | |
| Public officials | 9 | 4.1 | 8 | 1.1 | 5 | 0.8 | |
| Others | 66 | 29.9 | 71 | 9.9 | 64 | 10.6 | |
| Time of hospital visit | | | | | | 0.000 | |
| Within 3 days | 37 | 16.3 | 25 | 3.5 | 8 | 1.3 | |
| 4 days or after | 190 | 83.7 | 696 | 96.5 | 595 | 98.7 | |
| Abnormal physical findings | | | | | | | |
| Throat | 72/136 | 52.9 | 273/466 | 58.6 | 204/400 | 51.0 | 0.240 |
| Nose | 10/80 | 12.5 | 25/248 | 10.1 | 16/223 | 7.2 | 0.126 |
| Eye | 12/82 | 14.6 | 35/250 | 14.0 | 25/242 | 10.3 | 0.202 |
| Lung | 7/95 | 7.4 | 8/326 | 2.5 | 3/303 | 1.0 | 0.001 |
| Heart | 0/92 | 0.0 | 0/294 | 0.0 | 0/292 | 0.0 | - |
| Skin | 7/72 | 9.7 | 15/225 | 6.7 | 8/229 | 3.5 | 0.002 |
| Abnormal PFT | | | | | | | |
| FVC%† | 2/14 | 14.3 | 1/27 | 3.7 | 1/7 | 14.3 | 0.739 |
| FEV1/FVC%‡ | 0/14 | 0.0 | 2/27 | 7.4 | 0/7 | 0.0 | 0.747 |
* Chi-squared test for trend.
† Decreased FVC < 80%.
‡ Decreased FVC/FEV1 ratio <70%.
Chief complaints with respect to distance from the accident site
| Sore throat | 51 | 22.7 | 195 | 28.2 | 131 | 23.5 | 0.660 |
| Headache | 46 | 20.4 | 142 | 20.5 | 106 | 19.0 | 0.549 |
| Cough | 27 | 12.0 | 87 | 12.6 | 82 | 14.7 | 0.234 |
| Eye irritation | 21 | 9.3 | 58 | 8.4 | 47 | 8.4 | 0.742 |
| Shortness of breath | 18 | 8.0 | 29 | 4.2 | 19 | 3.4 | 0.012 |
| Chest pain | 11 | 4.9 | 33 | 4.8 | 18 | 3.2 | 0.190 |
| Dizziness | 9 | 4.0 | 27 | 3.9 | 17 | 3.0 | 0.423 |
| Nausea | 3 | 1.3 | 26 | 3.8 | 14 | 2.5 | 0.784 |
| Rhinorrhea | 2 | 0.9 | 13 | 1.9 | 26 | 4.7 | 0.001 |
| Skin burning | 5 | 2.2 | 13 | 1.9 | 16 | 2.9 | 0.405 |
| Itching | 5 | 2.2 | 13 | 1.9 | 9 | 1.6 | 0.557 |
| Sputum | 8 | 3.6 | 7 | 1.0 | 10 | 1.8 | 0.289 |
| Nasal pain | 2 | 0.9 | 3 | 0.4 | 9 | 1.6 | 0.137 |
| Skin rash | 1 | 0.4 | 4 | 0.6 | 0 | 0.0 | 0.169 |
| Vomiting | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 0.744 |
| Others | 12 | 5.3 | 16 | 2.3 | 20 | 3.6 | 0.548 |
| No symptom | 4 | 1.8 | 25 | 3.6 | 34 | 6.1 | 0.003 |
| Total | 225 | 100.0 | 692 | 100.0 | 558 | 100.0 | |
* Chi-squared test for trend.
Laboratory results with respect to distance from the accident site
| | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Complete blood cell count | | | | | | | | | |||
| WBC (×103/mm3) | 166 | 6.97 ± 1.60 | 488 | 7.11 ± 1.97 | 471 | 6.99 ± 1.88 | 0.548 | 0.500 | |||
| RBC (×106/mm3) | 166 | 4.88 ± 0.46 | 488 | 4.79 ± 0.48 | 471 | 4.70 ± 0.46 | 0.000 | 0.175 | |||
| Hemoglobin (g/dL) | 166 | 14.8 ± 1.73 | 488 | 14.7 ± 1.67 | 471 | 14.0 ± 1.65 | 0.000 | 0.172 | |||
| Hematocrit (%) | 166 | 44.1 ± 4.44 | 488 | 43.5 ± 4.25 | 471 | 41.9 ± 4.15 | 0.000 | 0.032 | |||
| Platelet (×103/mm3) | 166 | 252.8 ± 55.9 | 488 | 246.8 ± 51.0 | 471 | 254.6 ± 50.7 | 0.057 | 0.101 | |||
| Serum electrolyte | | | | | | | | | | | |
| Calcium (mg/dL) | 172 | 9.39 ± 0.37 | 489 | 9.35 ± 0.36 | 471 | 9.32 ± 0.37 | 0.106 | 0.226 | |||
| Phosphorus (mg/dL) | 172 | 3.57 ± 0.58 | 489 | 3.59 ± 0.57 | 471 | 3.74 ± 0.63 | 0.000 | 0.438 | |||
| Sodium (mmol/L) | 165 | 141.9 ± 1.93 | 485 | 142.0 ± 2.06 | 471 | 141.7 ± 1.79 | 0.055 | 0.611 | |||
| Potassium (mmol/L) | 165 | 4.13 ± 0.34 | 485 | 4.07 ± 0.32 | 471 | 4.04 ± 0.28 | 0.006 | 0.044 | |||
| Chloride (mmol/L) | 164 | 102.9 ± 2.04 | 485 | 103.1 ± 2.03 | 471 | 103.1 ± 1.84 | 0.438 | 0.778 | |||
| Serum chemistry | | | | | | | | | | | |
| AST† (IU/L) | 162 | 24.0 ± 10.8 | 476 | 25.3 ± 12.4 | 470 | 23.7 ± 13.5 | 0.161 | 0.310 | |||
| ALT‡ (IU/L) | 162 | 25.1 ± 16.6 | 476 | 26.9 ± 23.7 | 470 | 23.5 ± 25.1 | 0.087 | 0.466 | |||
| r-GTP§ (IU/L) | 155 | 36.8 ± 31.6 | 473 | 39.3 ± 52.3 | 466 | 27.5 ± 28.9 | 0.000 | 0.240 | |||
| ALP
| 158 | 180.6 ± 62.6 | 475 | 177.6 ± 51.2 | 467 | 195.8 ± 130.3 | 0.010 | 0.136 | |||
| Glucose (mg/dL) | 156 | 113.7 ± 48.5 | 461 | 105.5 ± 32.9 | 446 | 100.1 ± 20.9 | 0.000 | 0.038 | |||
| Total cholesterol (mg/dL) | 159 | 197.6 ± 36.0 | 475 | 194.7 ± 36.0 | 467 | 190.7 ± 35.5 | 0.065 | 0.816 | |||
| Blood urea nitrogen (mg/dL) | 161 | 13.9 ± 3.97 | 473 | 13.1 ± 3.89 | 468 | 12.7 ± 3.59 | 0.001 | 0.109 | |||
| Creatinine (mg/dL) | 162 | 0.88 ± 0.14 | 473 | 0.89 ± 0.18 | 469 | 0.81 ± 0.19 | 0.000 | 0.070 | |||
| Uric acid (mg/dL) | 152 | 5.62 ± 1.49 | 460 | 5.51 ± 1.47 | 444 | 5.12 ± 1.45 | 0.000 | 0.540 | |||
*Adjusted for age and sex, using ANCOVA test.
†Aspartate transaminase, ‡Alanine transaminase, §Gamma glutamyl transpeptidase, Alkaline phosphatase.